Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): Ohayo Japan | Markets Rattled by Tariff Threats and Soaring Inflation Fears and more

In today’s briefing:

  • Ohayo Japan | Markets Rattled by Tariff Threats and Soaring Inflation Fears
  • Japan Morning Connection: US Defense Secretary Hegseth Reconfirming Commitment to Japan
  • DeekSeek May Not Be The “Game Changer” In China Healthcare – Time to Be Rational


Ohayo Japan | Markets Rattled by Tariff Threats and Soaring Inflation Fears

By Mark Chadwick

  • Stocks plunged Friday as trade policy uncertainty and inflation concerns rattled markets. The  S&P 500 fell 2% and the Nasdaq sank 2.7%.
  • Mitsui Sumitomo Insurance will spend ¥420bn to acquire a 15% stake in US insurer W.R. Berkley, gaining expertise in specialty insurance.
  • SoftBank Group plans to invest around ¥1,000bn in industrial parks across the US, featuring AI-equipped factories. The parks will utilise humanoid robots and AI in production processes

Japan Morning Connection: US Defense Secretary Hegseth Reconfirming Commitment to Japan

By Andrew Jackson

  • Tech and AI down again ahead of Trump’s tariff ‘liberation day’ on April 2.
  • Wolfspeed -51% puts Renesas’s $2bn advance payment for SiC under jeopardy.
  • Dead rat, anyone? Should be positive for Yoshinoya as Sukiya shutters most stores.

DeekSeek May Not Be The “Game Changer” In China Healthcare – Time to Be Rational

By Xinyao (Criss) Wang

  • Although DeepSeek’s continuous updates, iterations, and deep integration with more and more healthcare enterprises in China will bring positive market sentiment, we have seen certain limitations and even risks behind.
  • Currently, AI healthcare relies heavily on government subsidies or hardware sales in China, which lacks sustainable payment scenarios and profit model. The data security/privacy/compliance issue may not be completely solve.
  • For the companies that have integrated with DeepSeek, investors need to verify their afterwards financial performance and fundamentals. If it does not meet expectations, investors are recommended sell in time.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars